Plasma apixaban concentrations and thrombin generation assay parameters in response to dose reduction for atrial fibrillation

Documenti analoghi

• Cardiovascular benefits of early rhythm control and healthy lifestyle in young atrial fibrillation
  di: Kyung‐Yeon Lee, et al.
  Pubblicazione: (2025)
• Comparison of Clinical Outcomes Between Left Bundle Branch Area Pacing With a Stylet‐Driven Lead and Conventional Right Ventricular Pacing
  di: Kyung‐Yeon Lee, et al.
  Pubblicazione: (2025)
• WoLF: Wide-scope Large Language Model Framework for CXR Understanding
  di: Kang, Seil, et al.
  Pubblicazione: (2024)
• Meta‐analysis evaluating apixaban in patients with atrial fibrillation and end‐stage renal disease requiring dialysis
  di: Ahmed AlTurki, et al.
  Pubblicazione: (2024)
• Frictional Q-Learning
  di: Kim, Hyunwoo, et al.
  Pubblicazione: (2025)